Shionogi joins CMAC as a Tier 1 Partner
Shionogi, a leading Japanese pharmaceutical company, has joined the CMAC consortium, marking a pivotal step in global collaboration and innovation.
Lonza joins CMAC to enhance service offering
Lonza has joined CMAC as a Translation to Industry Collaborator to enhance its service offering for specialty and enhanced drug product and particle technologies
New centre of excellence for regulation to accelerate digital adoption to ensure faster and safer delivery of medicines to patients
A new £1m research project to realise the transformative potential of digital technologies like artificial intelligence (AI) in medicines development and manufacturing has been announced.
The Centre of Excellence in Regulatory Science and Innovation (CERSI) project aims to advance regulatory processes by integrating cutting-edge digital technologies.
CMAC welcomes John Mack as Tier 2 Industry Board representative
CMAC has appointed John Mack as a new member of its Industry Board. Representing CMAC’s Tier 2 membership, John’s role will enhance the Tier 2 community's connection to CMAC’s activities, ensuring the centre stays at the forefront of manufacturing advancements and continues to meet the evolving needs of its members.
Meet our Team: Weiling Wang
Weiling’s research primarily focuses on data management and analysis for 3D printable biomaterials. Her day-to-day tasks include debugging code, reading research papers, and leading regular online catch-ups with colleagues in Nottingham.
Meet our Team: Christoph Busche
In his role at CMAC, Christoph is part of the analysis team, where he is responsible for keeping various instruments running and training others on their use. This is an important job, as analysis is a key component of every project, from industry initiatives to generating data for modelling.
Meet our Team: Natalie Maclean
In her current role as a Teaching Fellow, Natalie supports training and teaching within CMAC, particularly by contributing to the training curriculum for the new EPSRC-funded Centre for Doctoral Training in Cyber-Physical Systems for Medicine Manufacturing (CEDAR).
Meet our Team: Thomas McGlone
In the September edition of our 'Meet Our Team' series, we are delighted to celebrate Thomas McGlone, CMAC’s Senior Technical Operations Manager and Tier 2 Manager.
Leading global CDMO Ajinomoto Bio-Pharma Services joins CMAC as new Translation to Industry Collaborator.
Global CDMO Ajinomoto Bio-Pharma Services has become the first organisation to position itself as a Translation to Industry Collaborator within CMAC, a world-leading centre for medicines manufacturing at the University of Strathclyde.
digiM Solution partners with CMAC to revolutionise digital CMC processes
Together, CMAC and digiM will align to accelerate research and development within CMAC’s ambitious strategy for digital transformation of Chemistry, Manufacturing, and Control (CMC) processes.
CMAC ignites global research ambitions: Hosting Postdoctoral researchers for their prestigious Marie Skłodowska-Curie Actions Postdoctoral Fellowship
CMAC launches campaign encouraging postdoctoral researchers from around the globe, to apply for a prestigious Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship.
CMAC Summer School 2024
CMAC staff and students recently gathered at the Hilton Dunblane Hydro Hotel for CMAC’s annual Summer School, a week-long event featuring workshops, seminars, and networking opportunities.
CMAC’s New EPSRC MediForge Hub to Build Industry 5.0 Solutions to Transform the Sustainable Development and Manufacturing of Medicines
The EPSRC MediForge Hub will transform the development and manufacturing of medicines by pioneering an Industry 5.0 manufacturing system for sustainable, resilient, and human-centric medicine production.
Revolutionising Nanoparticle Production: Technical Evaluation Introduces Cutting-Edge Formulation Technology
In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, leon-nanodrugs GmbH (LEON), has proudly announced a pioneering technical evaluation by CMAC, University of Strathclyde.
CMAC’s new CEDAR EPSRC CDT to train 90 PhDs in Cyber-Physical Systems For Medicines Manufacturing
This ground-breaking CDT is set to revolutionise the pharmaceutical and technology sectors by addressing critical skills needs within the industry.
Malvern Panalytical Joins CMAC as Tier 2 Member
CMAC are thrilled to announce that we have welcomed Malvern Panalytical as a new Tier 2 member within our cutting-edge technology portfolio.
Sanofi Joins CMAC as Tier 1 Partner, Fostering Research & Innovation in Advanced Pharmaceutical Development & Manufacturing
This collaboration marks a significant milestone for the Centre in driving collaborative research and innovation within advanced pharmaceutical manufacturing.
CMAC and The Glasgow School of Art Team Up to Drive Transformation of Medicines Development and Manufacturing Through Augmented Reality
The University of Strathclyde’s medicines manufacturing research centre, CMAC, is delighted to announce the next phase in our strategic partnership with The Glasgow School of Art (GSA).
CMAC Data Lab: A Digital Medicine Manufacturing Research Accelerator
The University of Strathclyde’s Continuous Manufacturing and Advanced Crystallisation (CMAC) are delighted to announce a new £11 million award from UK Research Partnership Investment Fund (UKRPIF) to deliver the CMAC Data Lab: A Digital Medicine Manufacturing Research Accelerator.
CMAC Summer School 2023
Summer School is an annual, week-long programme that provides CMAC students and staff with the opportunity to collaborate with a variety of talented professionals who deliver insightful training throughout the week.